Skip to main content

Arax Advisory Partners

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1586767 DENVER, CO

Position in BCRX

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$202,860
+$198,053 QoQ
Shares Held
20,286
+3917.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#203
of 316 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Arax Advisory Partners holds $14,581,452 across 56 Drug Manufacturers - Specialty & Generic names. BCRX ranks #13 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BCRX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $202,860 20,286
2026-03-31 $4,807 505
2025-12-31 $358 46
2025-09-30 $22,716 2,993
2025-06-30 $6,298 703
2025-03-31 $8,332 1,111
2024-12-31 $5,549 738
2024-09-30 $5,608 738
2024-06-30 $4,808 778
2024-03-31 $426 84
2023-12-31 $311 52
2023-09-30 $368 52
2023-06-30 $366 52
2023-03-31 $425 51
2022-12-31 $436 38